These Appalachia hospitals made big promises to gain a monopoly. They’re failing to deliver.

Five years ago, rival hospital companies in this blue-collar corner of Appalachia made a deal. If state lawmakers let them merge, leaving no competitors, the hospitals promised not to gouge prices or cut corners.

Immunic to Participate in Scientific Conferences in October – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Conference 04.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

October 5, 2023

Arginine Starvation Boosts OS in Mesothelioma

First-line chemotherapy plus an investigational arginine-depleting agent improved survival in nonepithelioid pleural mesothelioma compared with chemotherapy alone, a randomized trial showed. For the study’s primary

February 17, 2024

Study identifies non-statin cholesterol drugs with potential to lower liver cancer risk

Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals’ risk of developing liver cancer.

July 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.